I’ve either been closely following, trading or invested in Starpharma for well over 20 years and I’m almost certain today was a first: Not a single solitary share was traded during the entire ASX trading day.
This milestone, along with the near record low 9 cent share price, plus the recent inglorious dumping from the All Ordinaries Index, as well as no longer having any broker coverage makes it offical: Starpharma is a penny dreadful stock.
Well done team Starpharma. Well done.
